Tejpal Gupta - Concepedia

Author

Tejpal Gupta

Also Known As

D. Bax, F Rickard, Gupta Tejpal, Gupta, T, T D Gupta, T Gupta, T. Gupta, TANISHI GUPTA, TAPASH DAS GUPTA, Tanusree Gupta

544

Publications

Citations

H-Index

127

Concepts

All Affiliations

Tata Memorial Hospital Advanced Centre for Treatment, Research and Education in Cancer Homi Bhabha National Institute Apollo Proton Cancer Centre

About

Tejpal Gupta is an author at Tata Memorial Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	59	3.8K
2	Health Sciences	21	35	1.6K
3	Engineering	1	1	33
4	Natural Sciences	1	1	20
5	Nursing	1	1	14

Tejpal Gupta

133

Publications

Citations

H-Index

Page 1

	Year	Citations
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial Roger Stupp, Monika E. Hegi, Thierry Gorlia, The Lancet Oncology Neuro-oncologyGliomaMedicineStandard TreatmentPathology	2014	1K
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines Vincent Grégoire, Mererid Evans, Quynh‐Thu Le, Radiotherapy and Oncology MedicineNcic CtgNasopharyngeal CancerPathologyLarynx	2017	379
Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups Arindam Maitra, Nidhan K. Biswas, Kishore Amin, Nature Communications	2013	356
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial Vanita Noronha, Amit Joshi, Vijay Patil, Journal of Clinical Oncology	2017	326
Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial Tejpal Gupta, Jaiprakash Agarwal, Sandeep Jain, Radiotherapy and Oncology Radiation TherapySquamous Cell CarcinomaThree-dimensional Conformal RadiotherapyMedicineVersus Intensity	2012	307
Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need? Sarbani Ghosh Laskar, Tejpal Gupta, Suman Vimal, Journal of Clinical Oncology	2003	202
Factors Influencing Neurocognitive Outcomes in Young Patients With Benign and Low-Grade Brain Tumors Treated With Stereotactic Conformal Radiotherapy Rakesh Jalali, Indranil Mallick, Debnarayan Dutta, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyNeuro-oncologyNeuropsychologyStereotactic Conformal RadiotherapyNeuroimaging	2009	143
Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): Evidence from a prospective randomized study Shrinivas Rathod, Tejpal Gupta, Sarbani Ghosh Laskar, Oral Oncology Quality Of LifeIntensity-modulated Radiation TherapyRadiation TherapyThree-dimensional Conformal RadiotherapyMedicine	2013	133
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer Vijay Patil, Vanita Noronha, Amit Joshi, Cancer	2019	127
Hypofractionated, palliative radiotherapy for advanced head and neck cancer Jai Prakash Agarwal, Bhushan Nemade, Vedang Murthy, Radiotherapy and Oncology Advanced HeadRadiation TherapyMedicineHead And Neck CancerNeck Oncology	2008	123

Page 1